BioRegenx, Inc. (BRGX)

BioRegenx Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	10	12	9	-	-	-
Market Cap Growth	-73.46%	44.15%	-	-	-	-
Enterprise Value	12	15	11	-	-	-
Last Close Price	0.01	0.01	0.01	-	-	-
PS Ratio	5.43	6.69	3.68	-	-	-
PB Ratio	-2.22	-2.73	-2.55	-	-	-
P/FCF Ratio	336.88	414.83	-	-	-	-
P/OCF Ratio	258.59	318.43	-	-	-	-
EV/Sales Ratio	6.59	7.88	4.57	-	-	-
EV/FCF Ratio	408.59	488.63	-	-	-	-
Debt / Equity Ratio	-0.49	-0.49	-0.64	-0.72	-1.20	-1.07
Debt / FCF Ratio	74.03	74.03	-	-	-	-
Net Debt / Equity Ratio	-0.47	-0.47	-0.62	-0.66	-1.19	-0.80
Net Debt / EBITDA Ratio	-4.83	-4.83	-0.49	-0.40	-3.27	-0.81
Net Debt / FCF Ratio	71.71	71.71	-4.10	-0.90	-3.72	-0.66
Asset Turnover	4.03	4.03	3.41	7.38	0.04	2.10
Inventory Turnover	3.22	3.22	4.15	-	-	1.90
Quick Ratio	0.03	0.03	0.02	0.08	0.01	0.30
Current Ratio	0.06	0.06	0.09	0.23	0.01	0.63
Return on Assets (ROA)	-70.55%	-70.55%	-595.83%	-460.70%	-4.95%	-106.97%
Return on Capital Employed (ROCE)	14.20%	14.20%	209.60%	177.40%	1366.40%	303.70%
Earnings Yield	-15.32%	-12.44%	-267.80%	-	-	-
FCF Yield	0.30%	0.24%	-5.96%	-	-	-
Buyback Yield / Dilution	-5.19%	-5.19%	-42.61%	-137.18%	-664.87%	-1.01%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.